Brief behavioral intervention for insomnia delivered via teleconsultation improves insomnia, anxiety, depression, and quality of life in COVID-19 survivors
In a randomized pilot trial, both teleconsultation and in-person brief behavioral interventions for insomnia significantly reduced insomnia severity (ISI from 14.57 to 5.57), anxiety (GAD-7 from 13.00 to 5.29), depression (PHQ-9 from 15.86 to 5.00), and improved quality of life (SF-36 from 30.00 to 77.14) at post-treatment and 3-month follow-up. The study concluded that teleconsultation is a viable treatment option for insomnia and mental health comorbidities.
This article is automatically generated from the structured evidence profile behind the claim above. Scores reflect the quality and quantity of available research, not clinical advice.
Brief behavioral intervention for insomnia delivered via teleconsultation improves insomnia, anxiety, depression, and quality of life in COVID-19 survivors The current body of evidence comprises 1 study, including 1 randomized controlled trial. EvidenceHub rates the overall confidence at 42/100 (low).
The Claim
Brief behavioral intervention for insomnia delivered via teleconsultation improves insomnia, anxiety, depression, and quality of life in COVID-19 survivors
This conclusion is most relevant to: Patients who survived COVID-19 infection with insomnia symptoms.
What the Research Shows
The conclusion draws on 1 linked study. Highlights from the cited literature:
- ▸Effectiveness of Brief Behavioral Intervention for Insomnia on Anxiety, Depression, Quality of Life, and Sleep: A Randomized Pilot Trial. (Cureus, 2026) —
How It Works
The proposed biological pathway:
- ▸Behavioral intervention targets sleep habits and routines
- ▸Reduces hyperarousal and maladaptive sleep behaviors
- ▸Improves sleep quality and reduces insomnia severity
- ▸Result: Reduced anxiety, depression, and improved quality of life
Who Might Benefit
Evidence fit by population:
- ▸Patients who survived COVID-19 infection with insomnia symptoms
Recommended Dose
N/A
Limitations & Caveats
Important context when interpreting this evidence:
- ▸Pilot trial with small sample size (not specified in abstract)
- ▸No passive control group, limiting causal inference
- ▸Results may not generalize to non-COVID-19 populations
Frequently Asked Questions
What is the brief behavioral intervention for insomnia?▼
It is a short-term therapy (4 weekly sessions of 50 minutes) focusing on behavioral changes to improve sleep, such as stimulus control and sleep restriction.
Is teleconsultation as effective as in-person therapy for insomnia?▼
Yes, the study found both modalities significantly improved insomnia, anxiety, depression, and quality of life, with no significant difference between them.
How long do the benefits last?▼
Improvements were maintained at the three-month follow-up, suggesting lasting effects.
Who can benefit from this intervention?▼
This study focused on COVID-19 survivors with insomnia, but the intervention may be applicable to other populations with insomnia symptoms.
References
- 1.Alvarez Garcia HB, Jimenez Correa U, Jiménez Genchi A. “Effectiveness of Brief Behavioral Intervention for Insomnia on Anxiety, Depression, Quality of Life, and Sleep: A Randomized Pilot Trial..” Cureus, 2026. PMID: 42534162 DOI: 10.7759/cureus.111676